Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
申请人:ELI LILLY AND COMPANY
公开号:EP0703218A1
公开(公告)日:1996-03-27
The present invention provides pyrrolidinyl di-carboxylic acid derivatives that affect certain excitatory amino acid receptors, and are useful in the treatment of neurological disorders and psychiatric disorders. This invention further provides novel pyrrolidinyl di-carboxylic acid derivatives and pharmaceutical formulations employing these novel compounds.
本发明提供了影响特定兴奋性氨基酸受体的吡咯烷二羧酸衍生物,并且在治疗神经系统疾病和精神疾病方面具有用途。本发明还提供了新型的吡咯烷二羧酸衍生物和使用这些新化合物的药物配方。